首页> 外文期刊>World Journal of Gastroenterology >Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease
【24h】

Correlation of ATP7B genotype with phenotype in Chinese patients with Wilson disease

机译:中国威尔逊病患者ATP7B基因型与表型的相关性

获取原文
获取原文并翻译 | 示例
       

摘要

AIM: To determine the mutational characterization of P-type ATP7B gene and to explore the correlation of ATP7B genotype to phenotype in Chinese patients with Wilson disease (WD). METHODS: Seventy-five patients with WD from 72 no-kinship families, 44 males and 31 females, were enrolled in this study. The age of onset ranged from 4 to 39 years, ≤18 years in 72 patients. Some exons of ATP7B gene mutations were analyzed in patients with WD by using biochemical methods, polymerase chain reaction-single strand configuration polymorphism (PCR-SSCP) and DNA sequence analysis. A total of 778 coding regions were identified with restriction enzyme Msp I. The activity of Cu-ATPase was assessed by measuring inorganic phosphorus. RESULTS: Sixty-six of 75 patients (88%) had with hepatic manifestations, 39 of them had only hepatic manifestations, 27 patients had hepatic and neurological manifestations or other symptoms at the same time (16 patients had associated neurological manifestation, 3 patients had osteopathy, 8 patients had other symptoms). Eight of the 75 patients (10.7%) had only neurological symptoms, one patient (5 years old) had no symptom. Twelve changing patterns were detected in ATP7B gene by DNA sequencing, including seven mutations (R778L, C656X, G943D, V1140A, V1106I V1216M and 1384del17), six polymorphisms (IVS4-5t/c, A2495G, C2310G, IVS18+6c/t and IVS20+5a/g). R778L occurred in 49/66 patients (74%) with hepatic manifestations, homozygosis of R778L in 16 patients, heterozygosity of R778L in 33 patients. V1106I mutation of ATP7B gene occurred in 2 patients with delaying onset of clinical symptoms. Cu-ATPase activity of three patients with known mutations (R778L/V1106I/A2495G, R778L/V1216M and R778L/R778L) were determined, and the activity of Cu-ATPase was decreased by 44.55%, 88.23% and 69.49% respectively. WD patients. R778L is the most common mutation of ATP7B gene. There is a correlation between R778L and hepatic manifestations in WD patient.
机译:目的:确定中国威尔逊病(WD)患者P型ATP7B基因的突变特征,探讨ATP7B基因型与表型的相关性。方法:来自72个非亲属家庭的75例WD患者,男性44例,女性31例。 72例患者的发病年龄为4至39岁,≤18岁。通过生化方法,聚合酶链反应-单链构型多态性(PCR-SSCP)和DNA序列分析,分析了WD患者中一些ATP7B基因突变的外显子。用限制酶Msp I鉴定出总共778个编码区。通过测量无机磷来评估Cu-ATP酶的活性。结果:75例患者中有66例(88%)具有肝表现,其中39例仅具有肝表现,27例同时具有肝和神经系统表现或其他症状(16例具有相关神经系统表现,3例具有肝表现)。骨病,8例有其他症状)。 75名患者中有8名(10.7%)仅具有神经系统症状,一名患者(5岁)没有症状。通过DNA测序在ATP7B基因中检测到十二种变化模式,包括七个突变(R778L,C656X,G943D,V1140A,V1106I V1216M和1384del17),六个多态性(IVS4-5t / c,A2495G,C2310G,IVS18 + 6c / t和IVS20 + 5a / g)。 R778L发生在有肝表现的49/66例患者中(74%),R778L的纯合子性16例,R778L的杂合性33例。 2例患者发生ATP7B基因的V1106I突变,延缓了临床症状的发作。测定了三个已知突变的患者(R778L / V1106I / A2495G,R778L / V1216M和R778L / R778L)的Cu-ATPase活性,其Cu-ATPase活性分别降低了44.55%,88.23%和69.49%。 WD患者。 R778L是ATP7B基因最常见的突变。 WD患者的R778L与肝表现之间存在相关性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号